glp-1 and perimenopause Weight Gain During Menopause: Solutions in the Era of GLP1-agonists Perimenopause And GLP-1 Weight Loss

JAMA Network Open, 6(5), e2314493

(NASDAQ: ALT) announced that pemvidutide received FDA Breakthrough Therapy designation for the treatment of MASH, further advancing development of the companys GLP-1/glucagon dual receptor agonist platform

Cai HY, Yang D, Qiao J, Yang JT, Wang ZJ, Wu MN, et al

This medical-grade resurfacing treatment clears out your pores and hydrates your skin which reduces fine lines and wrinkles, increases firmness, evens tone, texture, and brown spots, as well as reducing enlarged pores

Should I stop taking Ozempic if I have diverticulitis

Rather than outright removal, many insurers are opting to scale back coverage through tighter controls